Guided Therapeutics, Inc. (GTHP)
USD 0.11
(5.0%)
USD 0.11
(5.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.05 Million USD | -9.06% |
| 2022 | 2.26 Million USD | -21.94% |
| 2021 | 2.89 Million USD | -34.19% |
| 2020 | 4.4 Million USD | -26.82% |
| 2019 | 6.01 Million USD | 18.09% |
| 2018 | 5.09 Million USD | 9.8% |
| 2017 | 4.64 Million USD | 15.07% |
| 2016 | 4.03 Million USD | 156.78% |
| 2015 | 1.57 Million USD | -40.81% |
| 2014 | 2.65 Million USD | 974.49% |
| 2013 | 247 Thousand USD | -50.8% |
| 2012 | 502 Thousand USD | 19.24% |
| 2011 | 421 Thousand USD | -34.73% |
| 2010 | 645 Thousand USD | -92.59% |
| 2009 | 8.7 Million USD | 105.26% |
| 2008 | 4.23 Million USD | 56.65% |
| 2007 | 2.7 Million USD | -28.22% |
| 2006 | 3.77 Million USD | 889.5% |
| 2005 | 381 Thousand USD | 0.26% |
| 2004 | 380 Thousand USD | -62.64% |
| 2003 | 1.01 Million USD | 45.29% |
| 2002 | 700 Thousand USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | -100.0% |
| 1997 | 300 Thousand USD | 0.0% |
| 1996 | 300 Thousand USD | -37.5% |
| 1995 | 480 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.02 Million USD | -1.65% |
| 2024 Q2 | 2.14 Million USD | 5.78% |
| 2023 FY | 2.05 Million USD | -9.06% |
| 2023 Q1 | 2.11 Million USD | -6.72% |
| 2023 Q2 | 2.09 Million USD | -0.99% |
| 2023 Q3 | 2.08 Million USD | -0.24% |
| 2023 Q4 | 2.05 Million USD | -1.3% |
| 2022 Q1 | 2.84 Million USD | -2.04% |
| 2022 FY | 2.26 Million USD | -21.94% |
| 2022 Q2 | 3.04 Million USD | 7.29% |
| 2022 Q3 | 2.66 Million USD | -12.47% |
| 2022 Q4 | 2.26 Million USD | -15.15% |
| 2021 Q2 | 3.03 Million USD | 19.74% |
| 2021 Q1 | 2.53 Million USD | -42.38% |
| 2021 Q3 | 2.82 Million USD | -7.21% |
| 2021 FY | 2.89 Million USD | -34.19% |
| 2021 Q4 | 2.89 Million USD | 2.8% |
| 2020 FY | 4.4 Million USD | -26.82% |
| 2020 Q1 | 3.91 Million USD | -34.92% |
| 2020 Q2 | 3.9 Million USD | -0.41% |
| 2020 Q3 | 3.89 Million USD | -0.13% |
| 2020 Q4 | 4.4 Million USD | 13.06% |
| 2019 Q1 | 5.59 Million USD | 9.73% |
| 2019 Q4 | 6.01 Million USD | -0.31% |
| 2019 Q3 | 6.03 Million USD | 5.78% |
| 2019 Q2 | 5.7 Million USD | 2.06% |
| 2019 FY | 6.01 Million USD | 18.09% |
| 2018 FY | 5.09 Million USD | 9.8% |
| 2018 Q3 | 5.21 Million USD | 1.4% |
| 2018 Q1 | 4.86 Million USD | 4.7% |
| 2018 Q2 | 5.14 Million USD | 5.91% |
| 2018 Q4 | 5.09 Million USD | -2.34% |
| 2017 Q4 | 4.64 Million USD | -0.06% |
| 2017 FY | 4.64 Million USD | 15.07% |
| 2017 Q2 | 4.53 Million USD | 7.93% |
| 2017 Q3 | 4.64 Million USD | 2.52% |
| 2017 Q1 | 4.19 Million USD | 4.07% |
| 2016 Q4 | 4.03 Million USD | 8.38% |
| 2016 Q2 | 3.56 Million USD | 68.24% |
| 2016 Q3 | 3.72 Million USD | 4.55% |
| 2016 FY | 4.03 Million USD | 156.78% |
| 2016 Q1 | 2.11 Million USD | 34.69% |
| 2015 Q1 | 2.85 Million USD | 7.39% |
| 2015 Q2 | 2.18 Million USD | -23.19% |
| 2015 Q3 | 1.84 Million USD | -15.58% |
| 2015 FY | 1.57 Million USD | -40.81% |
| 2015 Q4 | 1.57 Million USD | -14.99% |
| 2014 Q4 | 2.65 Million USD | -30.74% |
| 2014 FY | 2.65 Million USD | 974.49% |
| 2014 Q2 | 3.19 Million USD | 443.03% |
| 2014 Q1 | 588 Thousand USD | 138.06% |
| 2014 Q3 | 3.83 Million USD | 20.01% |
| 2013 Q2 | 267 Thousand USD | -22.38% |
| 2013 FY | 247 Thousand USD | -50.8% |
| 2013 Q3 | 312 Thousand USD | 16.85% |
| 2013 Q1 | 344 Thousand USD | -31.47% |
| 2013 Q4 | 247 Thousand USD | -20.83% |
| 2012 Q1 | 399 Thousand USD | -5.23% |
| 2012 Q2 | 410 Thousand USD | 2.76% |
| 2012 Q4 | 502 Thousand USD | 20.38% |
| 2012 FY | 502 Thousand USD | 19.24% |
| 2012 Q3 | 417 Thousand USD | 1.71% |
| 2011 FY | 421 Thousand USD | -34.73% |
| 2011 Q4 | 421 Thousand USD | -18.25% |
| 2011 Q3 | 515 Thousand USD | -5.16% |
| 2011 Q2 | 543 Thousand USD | -6.38% |
| 2011 Q1 | 580 Thousand USD | -10.08% |
| 2010 FY | 645 Thousand USD | -92.59% |
| 2010 Q4 | 645 Thousand USD | -4.16% |
| 2010 Q3 | 673 Thousand USD | 3.22% |
| 2010 Q1 | 633 Thousand USD | -92.72% |
| 2010 Q2 | 652 Thousand USD | 3.0% |
| 2009 Q4 | 8.7 Million USD | 9.82% |
| 2009 FY | 8.7 Million USD | 105.26% |
| 2009 Q1 | 5.1 Million USD | 20.52% |
| 2009 Q2 | 5.77 Million USD | 12.94% |
| 2009 Q3 | 7.92 Million USD | 37.31% |
| 2008 Q3 | 4.94 Million USD | 21.91% |
| 2008 Q4 | 4.23 Million USD | -14.21% |
| 2008 FY | 4.23 Million USD | 56.65% |
| 2008 Q2 | 4.05 Million USD | 24.71% |
| 2008 Q1 | 3.25 Million USD | 20.1% |
| 2007 Q3 | 2.5 Million USD | 461.88% |
| 2007 Q4 | 2.7 Million USD | 7.98% |
| 2007 Q1 | 430 Thousand USD | -88.59% |
| 2007 Q2 | 446 Thousand USD | 3.72% |
| 2007 FY | 2.7 Million USD | -28.22% |
| 2006 Q3 | 3.6 Million USD | 26.95% |
| 2006 FY | 3.77 Million USD | 889.5% |
| 2006 Q1 | 2.3 Million USD | 504.72% |
| 2006 Q2 | 2.84 Million USD | 23.35% |
| 2006 Q4 | 3.77 Million USD | 4.49% |
| 2005 FY | 381 Thousand USD | 0.26% |
| 2005 Q4 | 381 Thousand USD | 178.1% |
| 2005 Q3 | 137 Thousand USD | -64.04% |
| 2005 Q2 | 381 Thousand USD | 0.0% |
| 2005 Q1 | 381 Thousand USD | 0.26% |
| 2004 Q2 | - USD | -100.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | 380 Thousand USD | 0.0% |
| 2004 Q1 | 17 Thousand USD | -98.33% |
| 2004 FY | 380 Thousand USD | -62.64% |
| 2003 Q3 | 1.05 Million USD | 31.25% |
| 2003 Q1 | 450 Thousand USD | -35.71% |
| 2003 FY | 1.01 Million USD | 45.29% |
| 2003 Q4 | 1.01 Million USD | -3.14% |
| 2003 Q2 | 800 Thousand USD | 77.78% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q4 | 700 Thousand USD | 0.0% |
| 2002 FY | 700 Thousand USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q4 | - USD | -100.0% |
| 2000 Q3 | 381 Thousand USD | 0.0% |
| 2000 Q2 | 381 Thousand USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 FY | - USD | -100.0% |
| 1998 Q1 | 300 Thousand USD | 0.0% |
| 1998 Q2 | - USD | -100.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1997 FY | 300 Thousand USD | 0.0% |
| 1997 Q2 | 300 Thousand USD | 0.0% |
| 1997 Q4 | 300 Thousand USD | 0.0% |
| 1997 Q3 | 300 Thousand USD | 0.0% |
| 1997 Q1 | 300 Thousand USD | 20.0% |
| 1996 FY | 300 Thousand USD | -37.5% |
| 1996 Q4 | 250 Thousand USD | 0.0% |
| 1995 FY | 480 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | 60 Thousand USD | -3329.998% |
| SS Innovations International, Inc. | 8.21 Million USD | 74.958% |
| Össur hf. | 467.73 Million USD | 99.56% |
| Össur hf. | 467.73 Million USD | 99.56% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| QHSLab, Inc. | 1.78 Million USD | -15.517% |
| BrainsWay Ltd. | 471 Thousand USD | -336.942% |
| BioElectronics Corporation | 14.83 Million USD | 86.124% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -357.859% |
| Zecotek Photonics Inc. | 3.22 Million USD | 36.124% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Wellstar International, Inc. | 51.36 Million USD | 95.994% |
| Hamilton Thorne Ltd. | 27.81 Million USD | 92.6% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | 60.56% |
| Escalon Medical Corp. | 524.71 Thousand USD | -292.21% |
| Aurora Spine Corporation | 2.67 Million USD | 22.938% |
| NewCardio, Inc. | 3 Million USD | 31.4% |
| Avitar, Inc. | 5.26 Million USD | 60.913% |
| Vivos Inc. | - USD | -Infinity% |
| Theraclion SA | 1.95 Million EUR | -5.499% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | -314.586% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | -1055.439% |
| Positron Corporation | 1.78 Million USD | -15.131% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | -207.164% |
| Nanomix Corporation | 11.4 Million USD | 81.957% |
| Wellness Center USA, Inc. | 4.04 Million USD | 49.084% |
| Stratec SE | 156.16 Million USD | 98.682% |
| Heart Tronics, Inc. | 209.28 Thousand USD | -883.348% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | 100 Thousand USD | -1957.999% |
| Electromedical Technologies, Inc. | 1.69 Million USD | -21.162% |
| Lombard Medical, Inc. | 32.29 Million USD | 93.627% |
| ALR Technologies Inc. | 19.26 Million USD | 89.317% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 99.879% |
| Vycor Medical, Inc. | 1.11 Million USD | -85.364% |
| VMS Rehab Systems, Inc. | 133.52 USD | -1541241.372% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | -966.907% |
| SANUWAVE Health, Inc. | 31.94 Million USD | 93.557% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | -226.068% |
| United American Healthcare Corporation | - USD | -Infinity% |
| Odyssey Group International, Inc. | 2.14 Million USD | 4.041% |
| IR-Med Inc. | 161 Thousand USD | -1178.26% |
| Polarean Imaging plc | 216.38 Thousand USD | -851.082% |
| ECGI Holdings, Inc. | 3.17 Million USD | 35.105% |
| Capital Group Holdings, Inc. | 4944.00 USD | -41526.193% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | -157.36% |
| Medical Supply International USA, Inc. | 227 Thousand USD | -806.6% |
| Urologix, Inc. | 5.33 Million USD | 61.41% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | 46.276% |
| Nexeon MedSystems Inc. | 4.21 Million USD | 51.177% |
| Qualis Innovations, Inc. | 9102.00 USD | -22510.404% |
| Smith & Nephew plc | 3.07 Billion USD | 99.933% |
| NIOX Group Plc | 1.4 Million USD | -46.968% |
| Fuse Medical, Inc. | 1.99 Million USD | -3.227% |
| Broncus Holding Corporation | 2.35 Million USD | 12.588% |
| Brain Scientific Inc. | 2.86 Million USD | 28.13% |
| Pressure BioSciences, Inc. | 22.75 Million USD | 90.957% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | -4988.767% |